Aprepitant for Cough Suppression in Advanced Lung Cancer: A Randomized Trial.

CONCLUSIONS: Aprepitant led to a significant improvement in cough in advanced lung cancer, without increasing severe side-effects.
PMID: 31958446 [PubMed - as supplied by publisher]

Source: Chest - January 16, 2020 Category: Respiratory Medicine Authors: Noronha V, Bhattacharjee A, Patil VM, Joshi A, Menon N, Shah S, Kannan S, Mukadam SA, Maske K, Ishi S, Prabhash K Tags: Chest Source Type: research